ReoPro and Retavase to Restore Brain Blood Flow After Stroke

Completed

Phase 2 Results

Summary of Purpose

This study will evaluate the safety and effectiveness of two types of blood thinners, abciximab (ReoPro) and reteplase (Retavase) for restoring normal brain blood flow after ischemic stroke (stroke resulting from a blood clot in the brain). The only therapy approved by the Food and Drug Administration to treat ischemic stroke is the clot buster drug rt-PA. This treatment, however, is effective only if begun...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 September 2011.

1 Mar 2002 12 Jun 2002 1 Apr 2007 1 May 2008 1 Sep 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Purpose: Treatment

Contacts

  • Section on Stroke Diagnostics and Therapeutics National Institute of Neurological Disorders and Stroke 10 Center Dr., Room B1D-733, MSC 1063 Bethesda, MD 20892-1063 301-435-9321 (phone) 301-480-0413 (fax)

    warachs@ninds.nih.gov